Loading. Please wait...
The International Lung Cancer Summit 2020
For single sessions, please scroll down
The power of social media in Oncology: what we can learn from our virtual peers
Gil Morgan, MD
Treatment standards in non-oncogene addicted NSCLC before COVID19
Maurice Pérol, MD
How can we treat patients with lung cancer during the SARS-CoV-2 pandemic?
Giuseppe Banna, MD
COVID19 & lung cancer: treatment & outcomes from a Spanish cohort
Antonio Calles, MD
Radiotherapy in lung cancer during the COVID-19 era
André Durham, MD-PhD
Mesothelioma: new therapeutic strategies and future perspectives for a difficult disease with a heavy social burden
Alessandra Curioni-Fontecedro, MD-PhD
Small cell lung cancer (SCLC): Treatment challenges and a glimpse into the development of new targets
Stephen V. Liu, MD
Personalized Medicine with IO: can we tailor immunotherapy options to patients?
Joshua Bauml, MD
Actionable mutations on the horizon: up and coming agents in targeted therapies
Christian Rolfo, MD-PhD
Tailoring targeted therapies: what TKI is suitable for what patient?
Howard (Jack) West, MD
Integrating immunotherapy into localized NSCLC
Sandip P. Patel, MD
Virtual Booth Section
We thank all our partners for their ongoing support with the
International Lung Cancer Summit
© 2020 International Lung Cancer Summit • email@example.com
• PEAK Medicals GmbH in collaboration with Hôpitaux Universitaires de Genève (HUG) & Centre hospitalier universitaire vaudois (CHUV)
Breitensteinstrasse 31 • 8037 Zurich • Switzerland •